Pembrolizumab Promising for Metastatic Head, Neck SCC

THURSDAY, Dec. 20, 2018 -- For patients with recurrent or metastatic head and neck squamous cell carcinoma, pembrolizumab has a favorable safety profile and is associated with prolongation of overall survival, according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news